
Metbleo Injection
Marketer
Metta Life Sciences Private Limited
Salt Composition
Bleomycin (15IU)
Overview Metbleo Injection
Oncaspar Injection is a medication employed in the treatment of diverse cancers, including cervical, oral, nasopharyngeal, and paranasal sinus cancers, as well as laryngeal, esophageal, and cutaneous malignancies. Its mechanism of action involves disrupting cancerous cell proliferation, leading to their eventual demise. Oncaspar Injection can be administered alone or in conjunction with other therapies. Administration must be under the strict supervision of a medical professional; self-administration is strictly prohibited. Dosage and frequency are determined by your physician, contingent upon your specific condition and may be adjusted over time. Adhere strictly to your physician's prescribed regimen. Improper usage or overdosage can result in severe adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; discontinue use only upon your doctor's instruction. Alcohol consumption should be avoided due to the potential for increased liver damage. Common side effects encompass fever, anorexia, alopecia, weight loss, nausea, interstitial pneumonia, dyspnea, and cough. Report any persistent or worsening side effects to your physician promptly; mitigation strategies may be available. This potent medication carries a risk of serious adverse reactions in some individuals. It can compromise immune function and potentially affect hematological, hepatic, or renal systems. Regular blood tests will be mandated to monitor these parameters. Prior to commencing treatment, inform your physician of any pre-existing gastrointestinal, hepatic, or renal conditions, as well as any concurrent medications, particularly anti-infectives. Numerous drug interactions are possible; disclose all medications currently in use. This medication is contraindicated during pregnancy and lactation due to potential fetal harm. Couples should employ contraception for several months following treatment cessation. Pre- and post-treatment monitoring may involve blood tests, radiography, and physical examinations.
Uses of Metbleo Injection
Cancers of the cervix, head and neck (including mouth, nose, throat, and esophagus), and skin.
Major Benefits of Metbleo Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Metbleo Injection:
- Fever
- Hair loss
- Interstitial pneumonia
- Loss of appetite
- Low blood platelets
- Nail discoloration
- Nausea
- Pulmonary fibrosis
- Rigors
- Scratch dermatitis
- Skin pigmentation
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Metbleo Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Metbleo Injection works:
Oncologists utilize Metbleo Injection, an antineoplastic agent, to disrupt the DNA of cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Metbleo Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Metbleo Injection during pregnancy is contraindicated due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Metbleo Injection while breastfeeding is likely inadvisable. Scant available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Metbleo Injection can produce adverse reactions that might impair driving capabilities. Similar to $med_name, a small number of patients have reported fatigue or weakness post-treatment, potentially impacting their ability to drive safely.
KidneyCAUTION
Exercise caution when administering Metbleo Injection to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Metbleo Injection appears to be well-tolerated by individuals with hepatic impairment. Existing evidence indicates dose modification for Metbleo Injection might be unnecessary in this population, but physician consultation is advised.
What if you forget to take Metbleo Injection :
NA
Facts to Know About Metbleo Injection
| Label | Value |
|---|---|
| Chemical Classification | Cancer-Fighting Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Cytotoxic alkaloids |
